News

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say ...
In some situations, employees undergoing serious medical issues request accommodations that would require extensive time away from work or ...
Revenue (GAAP) surged to $31.7 million, exceeding analysts’ expectations by 88.8% driven by strong ZURZUVAE growth. Net loss (GAAP) narrowed to $49.7 million. This revenue surge, exceeding analysts’ ...
That’s the promise behind a new innovation from Trellis Health: the first FDA-cleared, at-home postpartum lab panel designed ...
However, some have to deal with a great "enemy:" postpartum depression, a psychological blow after giving birth. Famous women ...